SOUTH SAN FRANCISCO, Calif. (KGO) -- As the demand for new drugs is growing, it's challenging the biotech industry to re-think its approach to making them for clinical trials. South San Francisco's ...
Genentech is the largest of more than 200 biotech companies within South San Francisco, and accounts for more than 40% of the city’s total approximately 11.5 million square feet of biopharma building ...
Nutley, NJ, shutdown leaves roughly equal staffs for parent company and its subsidiary. Three years after its acquisition by Roche, Genentech is still enough of an R&D powerhouse to retain its own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results